May 31, 2022
Andrew Morris is Professor of Medicine at the University of Toronto and Medical Director of the Sinai Health System – University Health Network Antimicrobial Stewardship Program. He is past Chair of the Antimicrobial Stewardship Committees for the Association of Medical Microbiology and Infectious Diseases Canada and the Society for Hospital Epidemiology of America (SHEA). Dr. Morris was appointed to the Canadian Government’s Expert Advisory Group on Antimicrobial Resistance (EAGAR) in 2015. He co-chairs the Drugs and Biologics Clinical Practice Guideline Working Group for Ontario’s COVID-19 Science Advisory Table.
Dr. Morris obtained his MD from the University of Toronto, where he subsequently completed training in Internal Medicine and Infectious Diseases. He went on to complete a master’s of Science degree in Epidemiology from the Harvard School of Public Health, while completing a Canadian Infectious Diseases Society (now AMMI Canada) research fellowship.
Dr. Morris has worked closely with regional, provincial, and federal governments and interprovincial organizations to help develop and coordinate antimicrobial stewardship efforts. He is widely sought as a speaker and consultant on antimicrobial stewardship, behaviour change, implementation, and quality improvement. He is an author of over 100 peer-reviewed publications.